Cadence Pharmaceuticals (NASDAQ: CADX ), a biopharmaceutical company focused on acquiring, in-licensing, developing and commercializing proprietary products principally for use in the hospital setting, announced today the appointment of Stephen L. Newman, M.D., to the company's board of directors. "We are very pleased to welcome Dr. Newman to our board